Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Profit After Tax: 2010-2018

Historic Profit After Tax for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -$33.1 million.

  • EyePoint Pharmaceuticals' Profit After Tax fell 453.67% to -$33.1 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$80.3 million, marking a year-over-year decrease of 364.08%. This contributed to the annual value of -$53.2 million for FY2018, which is 187.64% down from last year.
  • EyePoint Pharmaceuticals' Profit After Tax amounted to -$33.1 million in Q3 2018, which was up 3.78% from -$34.4 million recorded in Q2 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Profit After Tax peaked at $20.6 million during Q3 2014, and registered a low of -$34.4 million during Q2 2018.
  • In the last 3 years, EyePoint Pharmaceuticals' Profit After Tax had a median value of -$6.1 million in 2017 and averaged -$10.6 million.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Profit After Tax soared by 657.80% in 2014, and later crashed by 8,529.85% in 2017.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Profit After Tax stood at -$4.1 million in 2014, then fell by 27.26% to -$5.2 million in 2015, then spiked by 98.71% to -$67,000 in 2016, then slumped by 8,529.85% to -$5.8 million in 2017, then tumbled by 453.67% to -$33.1 million in 2018.
  • Its last three reported values are -$33.1 million in Q3 2018, -$34.4 million for Q2 2018, and -$7.0 million during Q1 2018.